NCT04484402 - Treatment of Patients With Inflammatory-dystrophic Diseases of the Cornea Using Autologous Stem Cells | Biotech Hunter

Enrollment

Participants

Timeline

Start Date

October 3, 2016

Primary Completion Date

December 30, 2019

Study Completion Date

December 30, 2019

Conditions

Corneal UlcerCorneal DiseaseCorneal Dystrophy

Interventions

BIOLOGICAL

mesenchymal stem cells

Autologous adipose-derived mesenchymal stem cells mixed with sodium hyaluronate 1% solution

BIOLOGICAL

limbal stem cells

Autologous adipose-derived limbal stem cells mixed with sodium hyaluronate 1% solution

OTHER

standard treatment

Standard treatment according to the Clinical protocols

Trial Locations (1)

Institute of Biophysics and Cell Engineering of National Academy of Sciences of Belarus, Minsk

All Listed Sponsors

collaborator

Belarusian State Medical University

OTHER

lead

Institute of Biophysics and Cell Engineering of National Academy of Sciences of Belarus

OTHER_GOV